2025-11-15 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc. (UNH) based on the data provided, presented in English with simplified metrics and commentary:

## UNH Stock Analysis (as of 2025-11-16)

**0. Executive Summary:**

UNH is currently underperforming the S&P 500 significantly, with recent stock performance indicating a concerning downward trend. Market Risk Indicator (MRI) is Medium Investment. Analyst consensus is generally positive (Buy), while news headlines present a mixed picture. Overall, the data suggests caution, with a potential need for further investigation before investment.

**1. Performance vs. S&P 500 (VOO):**

*   **Ticker:** UNH
*   **Company:** UnitedHealth Group Inc (a diversified healthcare company).
*   **UNH Cumulative Return:** -18.57%
*   **VOO Cumulative Return:** 98.45%
*   **Relative Deviation:**
    *   **Current:** -117.0
    *   **Max:** 36.3
    *   **Min:** -130.7
    *   **Relative Position:** 7.7 (The current deviation is near the worst end of its historical range).

**Analysis:** UNH has significantly underperformed the S&P 500. The relative deviation of -117.8 is concerning, especially considering its position near the historical low (7.7).

**Alpha/Beta Analysis:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
| :----------- | :---- | :---- | :---- | :--- | :----- |
| 2015-2017  | 58.0% | 66.4% | 30.0% | 0.0  | 206.3  |
| 2016-2018  | 41.0% | 70.4% | 26.0% | -0.0 | 233.1  |
| 2017-2019  | 36.0% | 73.8% | 14.0% | 0.2  | 275.1  |
| 2018-2020  | -43.0% | 81.2% | -67.0% | 0.5  | 328.2  |
| 2019-2021  | 16.0% | 81.2% | -31.0% | 1.5  | 469.9  |
| 2020-2022  | -1.0% | 81.2% | 0.0%  | 1.5  | 496.2  |
| 2021-2023  | 24.0% | 80.8% | 23.0% | 0.4  | 492.7  |
| 2022-2024  | -27.0% | 78.8% | -47.0% | 0.3  | 473.4  |
| 2023-2025  | -61.0% | 79.8% | -124.0% | 1.2  | 301.2  |

*   **CAGR (Compound Annual Growth Rate):** Fluctuates, with recent periods showing negative growth.
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant potential for losses.
*   **Alpha:** Shows a significant decrease, with recent years showing substantial negative alpha, indicating underperformance relative to a benchmark.
*   **Beta:** Generally low, suggesting less sensitivity to market movements, but has increased recently to 1.2.
*   **Cap(B):** Market capitalization, indicating the company's size.

**Analysis:** The historical Alpha/Beta analysis reveals a worrying trend of declining Alpha and increasing Beta, suggesting UNH is becoming more volatile and underperforming relative to market benchmarks. High MDD values indicate significant risk.

**2. Recent Stock Price Movement:**

*   **Current Price:** 321.86
*   **Previous Close:** 332.52
*   **Change:** -3.21 (-3.21%)
*   **5-Day Moving Average:** 328.49
*   **20-Day Moving Average:** 342.91
*   **60-Day Moving Average:** 340.50

**Analysis:** The current price is below all moving averages, signaling a potential short-term and medium-term downtrend. The recent price decrease (change = -3.21) confirms this bearish sentiment.

**3. Market Risk Indicators & Expected Return:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI (Relative Strength Index):** 24.19 (Oversold)
*   **PPO (Percentage Price Oscillator):** -0.59
*   **Hybrid Signal:** cash_79%_Sell 79.7% of holdings
*   **Recent Relative Deviation Change:** +1.9 (Short-term increase)
*   **Expected Return:** -185.1% (Long-term, relative to S&P 500)

**Analysis:** The RSI indicates that the stock is currently oversold, which can sometimes signal a potential for a bounce-back, but given other indicators, this could be a 'bear trap'. The very high negative expected return is alarming.  The Hybrid Signal's recommendation to sell a significant portion of holdings further reinforces the negative outlook. The MRI of 0.8 indicates "Medium Investment", but the Hybrid Signal "Sell" would indicate the opposite direction.

**4. Recent News & Significant Events:**

*   **Positive:** "3 Dow Jones Stocks with Promising Prospects" includes UNH (but needs further investigation). "Healthcare Stocks Are Blowing Past the S&P 500" (contradicts current UNH performance).
*   **Negative:** "David Tepper's Strategic Moves: UnitedHealth Group Inc Sees a -10.87% Portfolio Impact" implies a significant reduction in portfolio allocation to UNH by a major investor.
*   **Neutral:** Other news mentions UNH along with other companies (Apple, P&G).

**Analysis:** Recent news presents a mixed picture. The headline about David Tepper's firm reducing its UNH holdings is particularly concerning.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy (Mean: 2.00)
*   **Target Price:** 385.40 (Average)
*   **Opinions:** 25

**Analysis:** Analyst consensus remains positive, with a "Buy" rating. However, given the other negative indicators, it's important to understand the rationale behind these ratings and whether they have been recently updated.

**5. Recent Earnings Analysis:**

| Date       | EPS  | Revenue          |
| :----------- | :--- | :--------------- |
| 2025-10-28 | 2.59 | 113.16 B$       |
| 2025-08-11 | 3.76 | 111.62 B$       |
| 2025-05-07 | 6.9  | 109.58 B$       |
| 2024-11-04 | 6.56 | 100.82 B$       |
| 2025-10-28 | 6.56 | 100.82 B$       |

**Analysis:** While revenue has been increasing, the recent EPS (2.59) is significantly lower than previous quarters, and the identical date may mean duplicated data. The earnings data paints a mixed picture and warrants further investigation.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
| :----------- | :---------- | :-------------- |
| 2025-09-30 | $113.16B   | 18.24%        |
| 2025-06-30 | $111.62B   | 17.93%        |
| 2025-03-31 | $109.58B   | 21.70%        |
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE    |
| :----------- | :---------- | :----- |
| 2025-09-30 | $95.79B   | 2.45%  |
| 2025-06-30 | $94.72B   | 3.60%  |
| 2025-03-31 | $95.04B   | 6.62%  |
| 2024-12-31 | $92.66B   | 5.98%  |
| 2024-09-30 | $94.53B   | 6.41%  |

**Analysis:** Revenue is generally increasing, but profit margins and ROE have decreased in the most recent quarters. This trend warrants further investigation.

**7. Overall Summary:**

The analysis presents a mixed and concerning picture for UNH:

*   **Negative Performance:**  Significant underperformance compared to the S&P 500.
*   **Downtrend:** Recent stock price movement indicates a downtrend.
*   **Low RSI:** Oversold, but potentially a "bear trap".
*   **Negative Expected Return:** Extremely concerning negative projected return.
*   **Mixed News:** Recent news headlines are mixed, with negative news about a major investor reducing holdings.
*   **Decreasing profitability:** Recent EPS, profit margins, and ROE have decreased.
*   **Analyst Disagreement:** The "Buy" consensus from analysts is at odds with multiple negative indicators.
*   **Hybrid signal "sell":** The system analysis indicates to "sell".
*   **Relative Deviation is minimum:** Indicates "sell" side, however the recent relative deviation is increasing.

**Conclusion:** Based on this data, a cautious approach to UNH is advised. Further research is needed to understand the reasons behind the underperformance, decreasing profitability, and the discrepancy between analyst ratings and the hybrid rating system.
